Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Washington University in St. Louis at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Washington University in St. Louis brings 74 presentations to ASH 2026 in New Orleans. Its research spans acute myeloid leukemia, lymphoma and myeloma, from early drug trials to laboratory biology. It includes work such as a trial of an ATR inhibitor with decitabine in TP53-mutated leukemia and disparities in myeloma diagnosis.

OrganizationASH 2026 Attendance
Universities & research institutes
Private research university in St. Louis, Missouri, including the WashU School of Medicine.
Symposium
Fri Dec 11
11:00am–2:00pm
Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review
Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials.
Lymphoma · New drugs
Symposium
Fri Dec 11
7:00pm–10:00pm
Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know
Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research.
Lymphoma
Talk
Sat Dec 12
4:00pm–5:15pm
Update on the management of Extensive DVT
Recent trials on managing extensive deep vein thrombosis, and which patients benefit from catheter-directed clot removal for acute or chronic clots.
Clotting
Talk
Sun Dec 13
4:30pm–5:45pm
Structural Insights into Mechanisms
How an enzyme chemically modifies vitamin K dependent proteins, and how that step shapes blood clotting control, bone building, and blood vessel signaling.
Clotting
Session
Sun Dec 13
4:30pm–5:45pm
Rethinking Antiplatelet Strategies: Selective Blockade, Broad-Acting Drugs, and Beyond
Safer clot prevention by selectively blocking the platelet signals that grow a clot, instead of shutting platelets down and raising bleeding risk.
Clotting · New drugs
Talk
Sun Dec 13
4:30pm–5:45pm
Hematopoietic Stem Cell Transplantation in Severe Congenital Hemolytic Anemias
Using stem cell transplants from matched or mismatched donors, now safer, to cure severe inherited hemolytic anemias, even in very young children.
Red cells
Talk
Mon Dec 14
10:30am–11:45am
Vascular Anomalies: Understanding the Healthcare Experiences of Patients and Caregivers
What living with a rare vascular anomaly involves, from long diagnostic journeys and stigma to scarce experts, and how clinicians can help.
Clotting · New drugs
Session
Mon Dec 14
12:15pm–1:15pm
ASH Poster Walk on Leukemia in Latin America: Outcomes and Access to Diagnostics and Therapies Hosted by Blood Global Hematology
How access to diagnosis, molecular testing, new drugs, transplant and trials shapes leukemia outcomes across Latin America.
Leukemias · Patient care
Session
Mon Dec 14
4:30pm–6:00pm
Special Symposium on the Basic Science of Hemostasis and Thrombosis (SSBSHT)
New tools including multiomics, protein design, functional genomics, and AI applied to how blood clots form and dissolve, and to bleeding disorders.
Clotting

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Washington University in St. Louis

Tell us what you sell and we’ll find the people at Washington University in St. Louis most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction